IP Group Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 33

- Investments
- 374
- Portfolio
- 131
- Exits
- 96

IP Group General Information
Description
Founded in 2001, IP Group is a venture capital firm headquartered in London, England. The firm seeks to invest in early-stage to mature businesses operating in the healthcare, life science, technology, cleantech, and biotech sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 25 Walbrook, The Walbrook Building
- Top Floor
- London EC4N 8AF
- England, United Kingdom
+44 020 0000 0000
IP Group Investments & Acquisitions (374)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Oxbotica | 05-Jan-2021 | Later Stage VC | 000.00 | Business/Productivity Software | Generating Revenue | 00000 0000000000 |
0000000 0000000000 | 22-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
000000 | 03-Dec-2020 | 00000 00000 | 00.000 | Electronic Equipment and Instruments | Generating Revenue | 000000 0000000 00.0 |
000000000 | 27-Nov-2020 | 00000 00000 | 00.000 | Monitoring Equipment | Generating Revenue | |
00000000000 | 23-Oct-2020 | 00000 00000 | 00.000 | Electronics (B2C) | Startup | 000 00000000 00.0 |
00000000 | 07-Oct-2020 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000 00000 00.0 |
00000000000 | 21-Sep-2020 | 00000 00000 | 00.000 | Application Specific Semiconductors | Generating Revenue | 000 00000000 00.0 |
0000000 000000 | 03-Aug-2020 | 00000 00000 | 00.000 | Energy Storage | Generating Revenue | 00000 0000000000 |
TrekIT | 29-Jul-2020 | Seed Round | 00.00 | Other Healthcare Technology Systems | Generating Revenue | 0000000 00000000 |
Carisma Therapeutics | 08-Jul-2020 | Early Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials |
IP Group Exits (95)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Abingdon Health | 15-Dec-2020 | IPO | 000.00 |
0000000 | 09-Dec-2020 | 000000000000000000 | |
00000000 | 24-Nov-2020 | 00 000000000000000 | |
000000 00000 | 01-Nov-2020 | 000000000000000000 | 000.00 |
000 00 | 08-Jul-2020 | 000 00 00000000 | |
000000 0000000 000 | 10-Jun-2020 | 000000 0000000000 | 000.00 |
00000000 | 12-May-2020 | 000 00 00000000 | |
00000 | 17-Jan-2020 | 000000000000000000 | 0000 |
IP Assist | 14-Jan-2020 | Merger/Acquisition | |
Moltin | 13-Jan-2020 | Merger/Acquisition |
IP Group Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore IP Group‘s full profile, request access.
Request a free trialIP Group Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialIP Group Team (82)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Alan Aubrey | Chief Executive Officer, Executive Director & Board Member | 00 | 0 | 0 | London, United Kingdom |
Greg Smith | Chief Financial Officer, Executive Director & Board Member | 0 | London, United Kingdom | ||
David Baynes | Chief Operating Officer, Executive Director & Board Member | 00 | 0 | 0 | London, United Kingdom |
Lewis Liu Ph.D | Managing Director, Greater China & China Head, Cleantech | 0 | 0 | 0 | London, United Kingdom |
Joyce Xie | Managing Director, Greater China | London, United Kingdom |
IP Group Co-Investors (163)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Touchstone Innovations | 14 | 0 | 00 |
![]() |
![]() |
Parkwalk Advisors | 00 | 0 | 00 |
![]() |
![]() |
Oxford Sciences Innovation | 0 | 0 |
![]() |
![]() |
|
Woodford Investment Management | 0 | 0 | 0 |
![]() |
![]() |
Hostplus Superannuation Fund | 0 | 0 |
![]() |
![]() |